Picture of Agilent Technologies logo

A Agilent Technologies Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Agilent Technologies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

2020
October 31st
2021
October 31st
2022
October 31st
2023
October 31st
2024
October 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue5,3396,3196,8486,8336,510
Cost of Revenue
Gross Profit2,8373,4073,7223,4763,548
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses4,4934,9725,2305,4405,022
Operating Profit8461,3471,6181,3931,488
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes8421,3601,5041,3391,521
Provision for Income Taxes
Net Income After Taxes7191,2101,2541,2401,289
Net Income Before Extraordinary Items
Net Income7191,2101,2541,2401,289
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income7191,2101,2541,2401,289
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2.954.214.385.264.78
Dividends per Share